The emergence of artemisinin partial resistance in Africa: how do we respond?
Malaria, a major infectious disease, is primarily caused by Plasmodium falciparum infection in sub-Saharan Africa. ART-R, the most important class for treatment, has risen in eastern Africa due to single point mutations in the P falciparum kelch13 protein. Major priorities include expanding genomic surveillance for ART-R mutations, testing artemisinin-based regimens against uncomplicated and severe malaria, assessing ex-vivo drug susceptibilities, considering changes in treatment policy to deter ART-R spread, and accelerating the development of new antimalarial regimens to overcome its impacts. The emergence of ART-R in Africa is an urgent concern, necessitating increased efforts to characterize its spread and mitigate its impact.
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!